Semaglutide Use in Acute Pulmonary Embolism

Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.

NCT02970942 ·Status: COMPLETED ·Phase: PHASE2

Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction

NCT06557811 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet

NCT05429593 ·Status: COMPLETED ·Phase: PHASE1

Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity

NCT05444153 ·Status: WITHDRAWN ·Phase: PHASE3

Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes

NCT05040971 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Weekly Semaglutide Treatment on Energy Expenditure

NCT06390501 ·Status: COMPLETED ·Phase: NA

Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

NCT02453711 ·Status: COMPLETED ·Phase: PHASE2

Rebalancing the Fat Content of the Heart and Muscles

NCT07065383 ·Status: RECRUITING ·Phase: NA

Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

NCT03693430 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes

NCT05950516 ·Status: UNKNOWN ·Phase: PHASE3

Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo

NCT02079870 ·Status: COMPLETED ·Phase: PHASE1

A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity

NCT03842202 ·Status: COMPLETED ·Phase: PHASE1

Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults

NCT05786521 ·Status: COMPLETED ·Phase: PHASE4

A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity

NCT04187300 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo

NCT06577090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

NCT01800968 ·Status: COMPLETED ·Phase: PHASE2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.

NCT05419726 ·Status: RECRUITING

Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program

NCT03611582 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus

NCT06616961 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes

NCT02692716 ·Status: COMPLETED ·Phase: PHASE3

Semaglutide and Cognition in Healthy Volunteers

NCT06363487 ·Status: COMPLETED ·Phase: NA

Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.

NCT04251156 ·Status: COMPLETED ·Phase: PHASE3

A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice

NCT07055607 ·Status: ENROLLING_BY_INVITATION

Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss

NCT07280403 ·Status: COMPLETED ·Phase: NA